Hims & Hers Health, Inc. (HIMS) — Fair Value Analysis
Base-case fair value (P50): $29.31 · Current price: $32.26 · Verdict: Fairly Valued
The Verdict on HIMS
Our Monte Carlo simulations indicate HIMS (HIMS) is Fairly Valued. The current market price of $32.26 sits close to our median fair value (P50) of $29.31. This analysis suggests that while there isn't significant implied upside from the current level, given the -9.1%, the stock is priced appropriately based on thousands of forward-looking scenarios. Investors should note this implies a balanced risk-reward profile without the substantial margin of safety or compelling undervaluation that might attract deep value investors.
How HIMS stacks up against peers
HIMS exhibits an average quality tier, reflecting its operational and financial health relative to its peers. This means while HIMS is not facing significant distress, it also isn't demonstrating best-in-class metrics that would warrant a premium valuation or suggest exceptional resilience in various downside scenarios modeled by our simulations. The current valuation of $32.26 relative to our $29.31 aligns with this average quality profile, suggesting market pricing largely reflects its fundamental standing. Any significant deviation in $32.26 from $29.31 would warrant a re-evaluation of this fair value assessment.
What this means for investors
For investors considering HIMS, the current fair valuation derived from Monte Carlo simulations implies that the market is efficiently pricing the company. The $32.26 shows a -9.1% against the $29.31, reinforcing the "Fairly Valued" verdict. This suggests future returns are likely to be driven by operational execution and broader market movements, rather than a significant re-rating towards an undervalued fair price. Maintaining an average quality tier, HIMS requires consistent performance to uphold its fair value. Leverage the power of FairCurve to access the full probabilistic distribution for HIMS, including bear and bull case targets, and track its fair value as new fundamentals are released.
Frequently Asked Questions
Is HIMS overvalued or undervalued right now?
Based on our Monte Carlo simulations, HIMS is Fairly Valued. The current price of $32.26 is very close to our median fair value (P50) of $29.31.
What is the bear case and bull case for HIMS?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) targets, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate HIMS's fair value?
FairCurve calculates HIMS's fair value using advanced Monte Carlo simulations that model thousands of forward-looking scenarios based on a range of financial inputs and assumptions. This robust approach yields a probabilistic distribution of potential fair values.
How can I track HIMS's fair value as it changes?
You can add HIMS to your free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts when new earnings or significant fundamental data are released.